Chief Business Officer

OverviewBioPhase Solutions is seeking a highly accomplished, strategic, results-oriented Chief Business Officer (CBO) to spearhead our business development, corporate strategy, and investor relations initiatives. The ideal candidate will possess a deep understanding of the pharmaceutical industry, with a specific focus on the ophthalmic therapeutic area, a proven track record of successful deal-making, and significant experience in investment banking, particularly within the life sciences sector. The CBO will be a key member of the executive leadership team, responsible for identifying, evaluating, and executing strategic partnerships, M&A opportunities, and financing activities to drive the company's growth and maximize shareholder value. This is a high-impact, high-visibility role requiring a strategic thinker with a deep transaction experience, strong financial acumen, and the ability to influence at the executive level.Hybrid Key Responsibilities Strategic Partnerships & Business Development: Proactively identify, evaluate, and prioritize strategic business development opportunities, including licensing agreements, collaborations, joint ventures, and M&A, specifically within the ophthalmic drug development landscape. Lead all phases of the deal process from target identification, comprehensive scientific and commercial due diligence, financial modeling, valuation, negotiation, structuring, and closing of complex, value-creating transactions. Cultivate and maintain robust relationships with potential partners, including large pharmaceutical companies, ophthalmic specialty pharma, biotech firms, academic institutions, and contract research organizations globally, acting as an ambassador for our innovative pipeline. Develop and present compelling business cases and deal rationales to the executive team and Board of Directors, articulating the strategic fit and financial upside with a clear path to execution. Collaborate closely with the CEO and executive leadership to define and refine the company's long-term corporate strategy, ensuring alignment with our ophthalmic focus, including portfolio prioritization, market entry strategies for new ophthalmic drugs, and competitive positioning within the eye care market. Conduct in-depth market analysis, competitive intelligence, and industry trend assessment specific to the ophthalmic sector to inform bold and decisive strategic decision-making. Translate scientific advancements in ocular biology and drug delivery into compelling and commercially viable business propositions. Financing & Investor Relations: Lead and support all fundraising activities, including private placements, follow-on offerings, and debt financing, leveraging deep investment banking expertise. Develop and maintain strong relationships with investment banks, institutional investors, venture capitalists, and other financial stakeholders. Craft compelling investor presentations, financial models, and other materials to effectively communicate the company's value proposition and growth potential. Oversee investor relations activities, including investor communications, roadshows, and conferences. Alliance Management: Oversee the successful management of existing strategic alliances to ensure the realization of deal value and strong partner relationships. Resolve complex issues that may arise in partnerships. Build, mentor, and lead a high-performing business development and corporate strategy team, fostering a culture of excellence, entrepreneurial drive, collaboration, and accountability. Oversee certain other functions, including but not limited to: pre-product launch marketing, medical affairs, portfolio management, budgeting and resource allocations. Qualifications 15+ years of progressive experience in the pharmaceutical or biotechnology industry, with a significant portion of that experience in business development and corporate strategy leadership roles, ideally with a focus on ophthalmology. 5+ years of direct experience in investment banking, specifically within the life sciences or healthcare sector, is required. This includes experience with M&A advisory, equity capital markets (follow-on offerings), and debt financing. Demonstrated track record of successfully identifying, negotiating, and closing significant strategic transactions (licensing, M&A, collaborations) in the biotech/pharma space, with a preference for ophthalmic-related deals. Deep understanding of the drug discovery and development process, clinical trials, regulatory pathways (FDA, EMA), and commercialization strategies specific to ophthalmic drugs. Strong financial acumen and analytical skills, with the ability to build complex financial models and evaluate deal economics. Exceptional communication, presentation, and negotiation skills, with the ability to articulate complex scientific and business concepts to diverse audiences. Proven ability to build and maintain strong relationships with internal and external stakeholders. A true strategic thinker with a highly results-oriented mindset and a strong ability to execute in a fast-paced, innovative, and growth-oriented environment – an undeniable entrepreneurial spirit is a must. Bachelor's degree in a scientific discipline (e.g., Biology, Chemistry, Pharmacy) or Business/Finance. MBA (preferred) Please send resumes to and visit our website at for additional job opportunities!!! #J-18808-Ljbffr

Created: 2025-09-17